These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metagenomic next-generation sequencing for detecting Aspergillosis pneumonia in immunocompromised patients: a retrospective study. Shi Y, Peng JM, Hu XY, Yang QW, Wang Y. Front Cell Infect Microbiol; 2023; 13():1209724. PubMed ID: 38188627 [Abstract] [Full Text] [Related]
4. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients. Zhu N, Zhou D, Xiong W, Zhang X, Li S. Front Cell Infect Microbiol; 2023; 13():1271853. PubMed ID: 38029249 [Abstract] [Full Text] [Related]
5. Metagenomic next-generation sequencing for the diagnosis of invasive pulmonary aspergillosis in type 2 diabetes mellitus patients. Liu Z, Chen H, Chen D, Wu X, Xu H, Chen P, Wang R, Chen Y. Sci Rep; 2024 Jul 18; 14(1):16618. PubMed ID: 39025875 [Abstract] [Full Text] [Related]
6. Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis. Jia H, Liu H, Tu M, Wang Y, Wang X, Li J, Zhang G. Front Cell Infect Microbiol; 2023 Jul 18; 13():1223576. PubMed ID: 37692168 [Abstract] [Full Text] [Related]
11. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. Peng JM, Du B, Qin HY, Wang Q, Shi Y. J Infect; 2021 Apr 18; 82(4):22-27. PubMed ID: 33609588 [Abstract] [Full Text] [Related]
17. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA. Zhou X, Wu X, Chen Z, Cui X, Cai Y, Liu Y, Weng B, Zhan Q, Huang L. Front Cell Infect Microbiol; 2023 Apr 18; 13():1287496. PubMed ID: 38076456 [Abstract] [Full Text] [Related]